Berberine against gastrointestinal peptides elevation and mucous secretion in hyperthyroid diarrheic rats

Regulatory Peptides

Volumn 155, Issue 1-3, 2009, Pages 145-149

  Cheng, Zhi Feng ^a,b   Zhang, Ying Qi ^b   Liu, Feng Chen ^b  

^a HARBIN INSTITUTE OF TECHNOLOGY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Berberine; Diarrhea; Gastrointestinal peptide; Goblet cell; Hyperthyroidism

Indexed keywords

BERBERINE; GASTRIN; LIOTHYRONINE; MOTILIN; SOMATOSTATIN; THYROID HORMONE; THYROXINE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL VOLUME; COLON; CONTROLLED STUDY; DIARRHEA; DRUG MECHANISM; DUODENUM; EXPERIMENTAL MODEL; FREE THYROXINE INDEX; GASTROINTESTINAL MUCOSA; GOBLET CELL; HYPERTHYROIDISM; ILEUM; JEJUNUM; LIOTHYRONINE BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; TISSUE LEVEL; WEIGHT REDUCTION;

ANIMALS; ANTIDIARRHEALS; BERBERINE; COLON; DIARRHEA; DUODENUM; GASTRINS; GASTROINTESTINAL HORMONES; GOBLET CELLS; HYPERTHYROIDISM; JEJUNUM; MALE; MOTILIN; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; SOMATOSTATIN; THYROID HORMONES; VASOACTIVE INTESTINAL PEPTIDE;

RATTUS;

EID: 67349253048     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2008.12.008     Document Type: Article

References (31)

1. Tsai C.S., and Ochillo R.F. Pharmacological effects of berberine on the longitudinal muscle of the guinea-pig isolated ileum. Arch Int Pharmacodyn Ther 310 (1991) 116-131
2. Wu D.Z., Yuan J.Y., Shi H.L., and Hu Z.B. Palmatine, a protoberberine alkaloid, inhibits both Ca(2+)- and cAMP-activated Cl(-) secretion in isolated rat distal colon. Br J Pharmacol 153 (2008) 1203-1213
3. Yamamoto K., Takase H., Abe K., Saito Y., and Suzuki A. Pharmacological studies on antidiarrheal effects of a preparation containing berberine and geranii herba. Nippon Yakurigaku Zasshi 101 (1993) 169-175
4. Ellenbroek B.A., Zhang X.X., and Jin G.Z. Effects of (-)stepholidine in animal models for schizophrenia. Acta Pharmacol Sin 27 (2006) 1111-1118
5. Yang J., Wang H.D., Lu D.X., Wang Y.P., Qi R.B., Li J., et al. Effects of neutral sulfate berberine on LPS-induced cardiomyocyte TNF-alpha secretion, abnormal calcium cycling, and cardiac dysfunction in rats. Acta Pharmacol Sin 27 (2006) 173-178
6. Zhang D.M., Liu H.Y., Xie L., and Liu X.D. Effect of baicalin and berberine on transport of nimodipine on primary-cultured, rat brain microvascular endothelial cells. Acta Pharmacol Sin 28 (2007) 573-578
7. Rodriguez-Menchaca A., Ferrer-Villada T., Lara J., Fernandez D., Navarro-Polanco R.A., Sanchez-Chapula J.A., et al. Block of HERG channels by berberine: mechanisms of voltage- and state-dependence probed with site-directed mutant channels. J Cardiovasc Pharmacol 47 (2006) 21-29
8. Li F., Wang H.D., Lu D.X., Wang Y.P., Qi R.B., Fu Y.M., et al. Neutral sulfate berberine modulates cytokine secretion and increases survival in endotoxemic mice. Acta Pharmacol Sin 27 (2006) 1199-1205
9. Pan L.R., Tang Q., Fu Q., Hu B.R., Xiang J.Z., and Qian J.Q. Roles of nitric oxide in protective effect of berberine in ethanol-induced gastric ulcer mice. Acta Pharmacol Sin 26 (2005) 1334-1338
10. Luo Y., Hao Y., Shi T.P., Deng W.W., and Li N. Berberine inhibits cyclin D1 expression via suppressed binding of AP-1 transcription factors to CCND1 AP-1 motif. Acta Pharmacol Sin 29.5 (2008) 628-633
11. Pandey M.K., Sung B., Kunnumakkara A.B., Sethi G., Chaturvedi M.M., and Aggarwal B.B. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis. Cancer Res 68 (2008) 5370-5379
12. Leng S.H., Lu F.E., and Xu L.J. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. Acta Pharmacol Sin 25 (2004) 496-502
13. Zhang Y., Li X., Zou D., Liu W., Yang J., Zhu N., et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab 93 (2008) 2559-2565
14. Jia X., Chen Y., Zidichouski J., Zhang J., Sun C., and Wang Y. Co-administration of berberine and plant stanols synergistically reduces plasma cholesterol in rats. Atherosclerosis 201 (2008) 101-107
15. Kulkarni S.K., and Dhir A. On the mechanism of antidepressant-like action of berberine chloride. Eur J Pharmacol 589 (2008) 163-172
16. Oprins J.C., Meijer H.P., and Groot J.A. TNF-alpha potentiates the ion secretion induced by muscarinic receptor activation in HT29 cl.19A cells. Am J Physiol Cell Physiol 278 (2000) C463-C472
17. Field M. Intestinal ion transport and the pathophysiology of diarrhea. J Clin Invest 111 (2003) 931-943
18. Hiroi N., Sakamoto Y., Urita Y., Higa M., Kuboki K., and Yoshino G. Graves' disease with intractable diarrhea, chylous ascites, and chylothorax: a case report. Thyroid 17 (2007) 1299-1303
19. Hodak S.P., Huang C., Clarke D., Burman K.D., Jonklaas J., and Janicic-Kharic N. Intravenous methimazole in the treatment of refractory hyperthyroidism. Thyroid 16 (2006) 691-695
20. Portela-Gomes G.M., Albuquerque J.P., and Ferra M.A. Serotonin and gastrin cells in rat gastrointestinal tract after thyroparathyroidectomy and induced hyperthyroidism. Dig Dis Sci 45 (2000) 730-735
21. Kordasti S., Sjovall H., Lundgren O., and Svensson L. Serotonin and vasoactive intestinal peptide antagonists attenuate rotavirus diarrhoea. Gut 53 (2004) 952-957
22. Onoma M., Ozaki K., Yogo K., Monnai M., Muramatsu H., Kamei K., et al. Mitemcinal (GM-611), an orally active motilin receptor agonist, improves delayed gastric emptying in a canine model of diabetic gastroparesis. Clin Exp Pharmacol Physiol 35.7 (2008) 788-796
23. Xiao W., Liu J., and Liu L.Y. Effect of jianpi wenshen decoction on serum gastrin, plasma motilin and somatostatin in patients of diabetic diarrhea. Zhongguo Zhong Xi Yi Jie He Za Zhi 22 (2002) 587-589
24. El-Salhy M. Gastrointestinal transit in nonobese diabetic mouse: an animal model of human diabetes type 1. J Diabetes Complications 15 (2001) 277-284
25. Chen Q. Pharmcological methodologies for traditional chinese medicine. 1st ed. (1994), People's Health Publishing House (Beijing)
26. Lodish M.B., Powell A.C., bu-Asab M., Cochran C., Lenz P., Libutti S.K., et al. Insulinoma and gastrinoma syndromes from a single intrapancreatic neuroendocrine tumor. J Clin Endocrinol Metab 93 (2008) 1123-1128
27. Onoma M., Yogo K., Ozaki K., Kamei K., Akima M., Koga H., et al. Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs. Clin Exp Pharmacol Physiol 35 (2008) 35-42
28. Pinto H.C., Portela-Gomes G.M., Grimelius L., Kohnert K.D., and de Sousa J.C. The distribution of endocrine cell types of the gastrointestinal mucosa in genetically diabetic (db/db) mice. Gastroenterology 108 (1995) 967-974
29. Reindl T., Degenhardt P., Luck W., Riebel T., Sarioglu N., Henze G., et al. The VIP-secreting tumor as a differential diagnosis of protracted diarrhea in pediatrics. Klin Padiatr 216 (2004) 264-269
30. Dai D.Z., Hu H.J., Zhao J., Hao X.M., Yang D.M., Zhou P.A., et al. Blockade of L-type calcium channel in myocardium and calcium-induced contractions of vascular smooth muscle by CPU 86017. Acta Pharmacol Sin 25 (2004) 416-423
31. Hsieh M.T., and Wu L.Y. Inhibitory effects of (+/-)-tetrahydropalmatine on thyrotropin-stimulating hormone concentration in hyperthyroid rats. J Pharm Pharmacol 48 (1996) 959-961